Prescription Pricing for the People Act of 2019

This bill directs the Federal Trade Commission to report to Congress on the effect of certain anticompetitive practices in the pharmaceutical supply chain.

Learn more

Top Argument In Favor

Jerrold Nadler voted yea on behalf of 2 people via republicans-judiciary.house.gov
“Currently, some firms are able to raise their rivals’ costs or steer business to their own pharmacies and away from competitors. The study required by Prescription Pricing for People Act of 2019 will provide helpful guidance to Congress as it considers ways to stop this behavior and lower drug... show more
Endorse

Top Argument Against

No arguments against yet. Add one.


All Arguments

Jerrold Nadler voted yea on behalf of 2 people via republicans-judiciary.house.gov
“Currently, some firms are able to raise their rivals’ costs or steer business to their own pharmacies and away from competitors. The study required by Prescription Pricing for People Act of 2019 will provide helpful guidance to Congress as it considers ways to stop this behavior and lower drug... show more
Endorse
"[Pharmacy Benefits Managers] have an important role to play in America’s health care system, but too often they operate in the shadows, manipulating drug prices, steering patients and engaging in other anticompetitive behaviors that increase costs and force out community pharmacies. The... show more
Endorse
Liquid

Liquid makes democracy smarter and more accountable.


This is a new nation, based on a mighty continent, of boundless possibilities.

President Theodore Roosevelt

July 1917

Help